Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
PKU cooler20 liquid (5 flavours)
0913205N0BBAHAF
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 500 |
|
PKU Lophlex LQ 20 liquid (6 flavours)
0913205N0BBAAAA
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 471 |
|
PKU Air20 red liquid
0913205N0BBAEAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 141 |
|
PKU Air20 white liquid
0913205N0BBAFAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 59 |
|
PKU Air20 green liquid
0913205N0BBADAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 44 |
|
PKU Air20 gold liquid
0913205N0BBACAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 43 |
|
PKU Lophlex Select 20 liquid
0913205N0BBAIAH
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 38 |
|
PKU Air20 yellow liquid
0913205N0BBAGAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 29 |
|
PKU Lophlex Sensation 20
0913205N0BBABAC
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.